Psychosocial Burden of Localised Cutaneous Leishmaniasis: a Scoping Review

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2018 Mar 17

PMID 29544463

Citations 43

Authors

Issam Bennis

Vincent De Brouwere

Zakaria Belrhiti

Hamid Sahibi

Marleen Boelaert

Affiliations

Soon will be listed here.

Abstract

Background: Cutaneous Leishmaniasis (CL) is a parasitic skin disease, linked to poverty, and belonging to the group of Neglected Tropical Diseases. Depending on the severity, the type of lesions or scars, and the context, CL can lead to self- and social stigma influencing the quality of life and psychological well-being of the patient. This dimension is, however, little documented for the most common, localized form of cutaneous leishmaniasis (LCL). We aimed to describe the current knowledge on the psychological burden and the stigma related to LCL.

Methods: The population of interest for this scoping review are patients or their relatives with localized LCL or related scars. We searched the electronic databases PubMed, Web of Knowledge, PsycINFO, POPLINE, Cochrane Library, Science Direct, Global Health, and LILACS, for articles written in Arabic, English, French, Dutch, Portuguese, or Spanish, and published until the end of August 2017.

Results: From 2485 initial records, 15 papers met our inclusion criteria. Dermatology life quality index was the most frequent used scale to assess LCL psychological impact in quantitative studies. Six qualitative studies used individual interviews and/or focus groups discussions to explore the psychological and/or the social burden of this disease. Quantitative assessments using standard scales as well as qualitative research asserts that LCL is a source of psychological suffering, stigmatization, and decreased quality of life (QoL).

Conclusion: Most studies showed that LCL has a significant negative effect on the QoL and mental health. However, the fact that the psychosocial burden generated by LCL is time-dependent makes it hard to measure. We recommend to develop a more specific and validated assessment scale to appreciate the full burden of this disease and enhance comparability of findings.

Citing Articles

Effects of cutaneous leishmaniasis on patients' quality of life.

Yizengaw E, Nibret E BMC Infect Dis. 2024; 24(1):598.

PMID: 38890616 PMC: 11186278. DOI: 10.1186/s12879-024-09518-3.

Stigma experiences, effects and coping among individuals affected by Buruli ulcer and yaws in Ghana.

Tuwor R, Mtuy T, Amoako Y, Owusu L, Oppong M, Agbanyo A PLoS Negl Trop Dis. 2024; 18(4):e0012093.

PMID: 38683858 PMC: 11081504. DOI: 10.1371/journal.pntd.0012093.

Prevalence, assessment and correlates of mental health problems in neglected tropical diseases: a systematic review.

Adjorlolo S, Adimado E, Setordzi M, Akorli V Int Health. 2024; 16(Supplement_1):i12-i21.

PMID: 38547348 PMC: 10977955. DOI: 10.1093/inthealth/ihae001.

Perceived Social Stigma of Cutaneous Leishmaniasis in Hubuna, Saudi Arabia.

Elfaki N, Alzahrani M, Abdalla Y, Adeh A, Osman Abdalla A, Alkhadher M J Multidiscip Healthc. 2024; 17:867-876.

PMID: 38434481 PMC: 10909324. DOI: 10.2147/JMDH.S454135.

Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development.

Castro M, Erber A, Arana B, Cota G, Denkinger C, Harrison N PLoS Negl Trop Dis. 2024; 18(2):e0011975.

PMID: 38381805 PMC: 10965092. DOI: 10.1371/journal.pntd.0011975.

References

Peters M, Godfrey C, Khalil H, McInerney P, Parker D, Soares C . Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015; 13(3):141-6. DOI: 10.1097/XEB.0000000000000050. View

Lilly E, Lu P, Borovicka J, Victorson D, Kwasny M, West D . Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2012; 69(1):e11-8. DOI: 10.1016/j.jaad.2012.01.038. View

Chernyshov P, Zouboulis C, Tomas-Aragones L, Jemec G, Manolache L, Tzellos T . Quality of life measurement in acne. Position Paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol. 2017; 32(2):194-208. DOI: 10.1111/jdv.14585. View

Olliaro P, Grogl M, Boni M, Carvalho E, Chebli H, Cisse M . Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation. PLoS Negl Trop Dis. 2018; 12(1):e0006141. PMC: 5785032. DOI: 10.1371/journal.pntd.0006141. View

Kensinger E, Piguet O, Krendl A, Corkin S . Memory for contextual details: effects of emotion and aging. Psychol Aging. 2005; 20(2):241-50. DOI: 10.1037/0882-7974.20.2.241. View

Reithinger R, Dujardin J, Louzir H, Pirmez C, Alexander B, Brooker S . Cutaneous leishmaniasis. Lancet Infect Dis. 2007; 7(9):581-96. DOI: 10.1016/S1473-3099(07)70209-8. View

de Zeeuw J, Omansen T, Douwstra M, Barogui Y, Agossadou C, Sopoh G . Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin. PLoS Negl Trop Dis. 2014; 8(11):e3303. PMC: 4230927. DOI: 10.1371/journal.pntd.0003303. View

Ebner N, Fischer H . Emotion and aging: evidence from brain and behavior. Front Psychol. 2014; 5:996. PMC: 4158975. DOI: 10.3389/fpsyg.2014.00996. View

Egan M, Tannahill C, Petticrew M, Thomas S . Psychosocial risk factors in home and community settings and their associations with population health and health inequalities: a systematic meta-review. BMC Public Health. 2008; 8:239. PMC: 2503975. DOI: 10.1186/1471-2458-8-239. View

10.

Vogel D, Bitman R, Hammer J, Wade N . Is stigma internalized? The longitudinal impact of public stigma on self-stigma. J Couns Psychol. 2013; 60(2):311-316. DOI: 10.1037/a0031889. View

11.

Kober C, Habermas T . How stable is the personal past? Stability of most important autobiographical memories and life narratives across eight years in a life span sample. J Pers Soc Psychol. 2017; 113(4):608-626. DOI: 10.1037/pspp0000145. View

12.

Yanik M, Gurel M, Simsek Z, Kati M . The psychological impact of cutaneous leishmaniasis. Clin Exp Dermatol. 2004; 29(5):464-7. DOI: 10.1111/j.1365-2230.2004.01605.x. View

13.

Okwa O . Tropical parasitic diseases and women. Ann Afr Med. 2008; 6(4):157-63. DOI: 10.4103/1596-3519.55704. View

14.

Fernando S, Siriwardana H, Guneratne K, Rajapaksa L . Some sociological aspects of cutaneous leishmaniasis in patients attending a tertiary referral centre in Colombo, Sri Lanka. Int Health. 2013; 2(1):69-74. DOI: 10.1016/j.inhe.2009.12.002. View

15.

Senol A, Yucelten A, Ay P . Development of a quality of life scale for vitiligo. Dermatology. 2013; 226(2):185-90. DOI: 10.1159/000348466. View

16.

Simsek Z, Ak D, Altindag A, Gunes M . Prevalence and predictors of mental disorders among women in Sanliurfa, Southeastern Turkey. J Public Health (Oxf). 2008; 30(4):487-93. DOI: 10.1093/pubmed/fdn025. View

17.

Bradbury E . Meeting the psychological needs of patients with facial disfigurement. Br J Oral Maxillofac Surg. 2011; 50(3):193-6. DOI: 10.1016/j.bjoms.2010.11.022. View

18.

Chahed M, Bellali H, Ben Jemaa S, Bellaj T . Psychological and Psychosocial Consequences of Zoonotic Cutaneous Leishmaniasis among Women in Tunisia: Preliminary Findings from an Exploratory Study. PLoS Negl Trop Dis. 2016; 10(10):e0005090. PMC: 5082956. DOI: 10.1371/journal.pntd.0005090. View

19.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

20.

Stavrou D, Weissman O, Tessone A, Zilinsky I, Holloway S, Boyd J . Health related quality of life in burn patients--a review of the literature. Burns. 2014; 40(5):788-96. DOI: 10.1016/j.burns.2013.11.014. View